Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/04/21 → 31/12/25 |
Keywords
- Myelodysplastic syndrome
- Blood cancer
- Clinical trial
A Phase 1b, multicenter, open-label platform study of select drug combinations in adult patients with lower risk (very low, low, or intermediate risk) myelodysplastic syndrome
- Tiong, Ing Soo (Primary Chief Investigator (PCI))
- Teh, Tse-Chieh (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research